Can a Phone-Based program help heavy drinkers with liver disease cut back?
NCT ID NCT05191446
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 29 times
Summary
This study tests a stepped alcohol treatment program delivered via telemedicine for 180 adults with chronic liver disease who drink heavily. Participants are randomly assigned to either the program (motivational interviewing sessions plus possible referral to addiction medicine) or usual care. The goal is to see if the program helps reduce alcohol use and improve liver health over 6 to 12 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of california San Francisco
San Francisco, California, 94110, United States
-
Zuckerberg San Francisco General Hospital
San Francisco, California, 94110, United States
Conditions
Explore the condition pages connected to this study.